Newbridge Financial Services Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Newbridge Financial Services Group's EDIT Position: Q4 2025 in Review
Newbridge Financial Services Group sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 300 shares — an estimated $1.04K sold.
Newbridge Financial Services Group first reported a position in EDIT in Q3 2020 and held it in 21 quarters. The position peaked at $158K in Q2 2021. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.
- Newbridge Financial Services Group reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
- Newbridge Financial Services Group sold 300 Editas Medicine shares in Q4 2025, an estimated $1.04K.
- Newbridge Financial Services Group first reported a position in Editas Medicine in Q3 2020 and held it in 21 quarters.
- Newbridge Financial Services Group's Editas Medicine position peaked at $158K in Q2 2021.
- 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.
Based on Newbridge Financial Services Group's 13F filing for Q4 2025, filed 21 Jan 2026.